The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor
Abstract
Epidermal growth factor (EGF) receptor from A-431 cells was purified by affinity chromatography with monoclonal anti-receptor antibodies. The purified radiolabeled receptor was incubated with EGF and then analyzed by gel electrophoresis under nondenaturing conditions. In these gels, the EGF receptor migrates in two forms: a fast-migrating (low) form and an EGF-induced slow-migrating (high) form. On the basis of the various control and calibration experiments described, it is concluded that the low form represents the monomeric 170-kilodalton EGF receptor and the high form represents an EGF receptor dimer. The binding of EGF causes a rapid, temperature-sensitive dimerization of the EGF receptor. Receptor dimerization is fully reversible and involves saturable, noncovalent interactions that are stable at neutral pH and in nonionic detergents. Both the monomeric and dimeric forms of the receptor bind EGF and undergo self-phosphorylation. The dimeric form of the receptor may possess higher ligand binding affinity, and it seems to be phosphorylated earlier than the monomeric form following the addition of EGF and [gamma-32P]ATP. On the basis of these results, it is concluded that receptor oligomerization is an intrinsic property of the occupied EGF receptor and that it may play a role in the activation of the kinase function and the subsequent transmembrane signaling process.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidermal growth factor receptor (EGFR), a member of the receptor tyrosine kinase family, is a typical transmembrane receptor that initiates signaling cascades upon ligand-stimulated dimerization, thereby activating its tyrosine kinase and multiple downstream effectors.99–101”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [101]
Citations
Cites
Ullrich, A., Coussens, L. M., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., et al. (1984) · Nature · doi:10.1038/309418a0 · Cited by 2,751
Self-citationHuman insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L., Dull, T. J., Gray, A., Coussens, L. M., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
An enzymic method for the trace iodination of immunoglobulins and other proteins
Marchalonis, J. J. (1969) · Biochemical Journal · doi:10.1042/bj1130299 · Cited by 1,393
Three-Dimensional Structure of Immunoglobulins
Amzel, L. M., & Poljak, R. J. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.004525 · Cited by 697
Carpenter, G., King, L. E., & Cohen, S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30094-7 · Cited by 529
Haigler, H. T., McKanna, J. A., & Cohen, S. (1979) · The Journal of Cell Biology · doi:10.1083/jcb.81.2.382 · Cited by 526
Gill, G. N., Kawamoto, T., Cochet, C., Le, A. D., Sato, J. D., Masui, H., McLeod, C., & Mendelsohn, J. M. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42857-2 · Cited by 455
Schreiber, A. B., Libermann, T. A., Lax, I., Yarden, Y., & Schlessinger, J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33127-2 · Cited by 328
Self-citationKris, R., Lax, I., Gullick, W. J., Waterfield, M. D., Ullrich, A., Fridkin, M., & Schlessinger, J. (1985) · Cell · doi:10.1016/0092-8674(85)90210-7 · Cited by 295
Self-citationProduction of an Epidermal Growth Factor Receptor-Related Protein
Weber, W., Gill, G. N., & Spiess, J. (1984) · Science · doi:10.1126/science.6324343 · Cited by 202
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–629 of 629
Warrier, V. P., Paruchuri, A., Sakthivel, R., Gromiha, M. M., & Karunagaran, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.29.526080
Büyükşimşek, M., Tohumcuoğlu, M., Sedef, A. M., Bahçeci, A., Nayır, E., Yılmaz, M., Temi, Y. B., Beşen, A. A., Diker, Ö., Şimşek, M., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1538
Elucidating Reaction Mechanism of Gefitinib- An Anticancer Drug by Computational Technique
Chavan, A. B., Reddy, S. M., & Chaitanya, G. K. (2024) · Oriental Journal Of Chemistry · doi:10.13005/ojc/400327
EGFR Activation and Conformational “Convergence”: An Emerging Allosteric Model From Cancer Mutations
Orellana, L. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169493
Friedländer, E. (2008) · University of Debrecen Electronic Archive (University of Debrecen)
Evidence for the Role of Immobilization of Ligand-Occupied Membrane Receptors in Signal Transduction
Jans, D. A. (1997) · Molecular biology intelligence unit · doi:10.1007/978-1-4757-0680-2_7
Soluble, but not precursor EGF induces intracrine signaling of the EGFRPreprint
Bilakovics, N., Volkó, J., Jeppesen, C., Fekete, G. J., Csomós, I., Bodnár, A., Mocsár, G., Németh, K., Kormos, A., Tóth, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.28.691129
Riera, R., Fitzpatrick, L. W., Huet, S., Tholen, M. M. E., Jacquot, P., Cinier, M., Woythe, L., Tanou, M., Izquierdo-Lozano, C., Verhoeven, M., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11933
Sevenless: its function and structure in the specification of the Drosophila R7 photoreceptor
Tomlinson, A. (2026) · Genetics · doi:10.1093/genetics/iyag084
Macdonald-Obermann, J. L., Cho, K., Patti, G. J., & PIKE, L. J. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113230
Nag, S., Thakur, D., & Sharma, K. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2688859
Mena EVH1 Interacts with PTP1B Via a Distributed Interface Without Regulating Enzymatic Activity
LaComb, L., Cahill, S. M., Bonanno, J. B., Cowburn, D., Almo, S. C., & Ghosh, A. (2026) · Biochemistry · doi:10.1021/acs.biochem.6c00299
Schlessinger, J. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0498
Self-citationThe epidermal growth factor receptor—the prototypic RTK—turns 40
Hunter, T. R. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0495
Epidermal growth factor receptor: mechanisms, networks, and medicines
Lemmon, M. A., Ferguson, K. M., Leahy, D. J., McDonald, N. Q., & Francavilla, C. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0493
Roberts, S. K., Clarke, D., Galdadas, I., & Martin-Fernandez, M. L. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0513
Ligand bias in the EGF receptor system
PIKE, L. J. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2025.0050
Targeting EGFR in lung cancer: lessons in signal transduction and treatment-induced mutagenesis
Nieves, A. S., Daele, M. V., Konsker, H. B., & Yarden, Y. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0512
Self-citationGhosh, M., & Sharma, K. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.147484
From single to dual targeting: Recent advances in EGFR-based dual inhibitors for cancer therapy
YALCIN, Z. S., Alagöz, M. A., & Algül, Ö. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119400
BindingDB Entry 50018713: Recent advancement of piperidine moiety in treatment of cancer- A review.
BindingDB (2024) · UC San Diego · doi:10.7270/q22f7spv
Clathrin and TOM1L1 regulate Epidermal Growth Factor Receptor Signaling at the Plasma Membrane
Judge, G., Garay, C., Lucarelli, S., Bautista, S. J., Pandey, R., & Antonescu, C. N. (2015) · The FASEB Journal · doi:10.1096/fasebj.29.1_supplement.lb102
Björkelund, H. (2013) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Bitler, B. G. (2010) · UA Campus Repository (The University of Arizona)
The Mobile Receptor Hypothesis: A Global View
Jans, D. A. (1997) · Molecular biology intelligence unit · doi:10.1007/978-1-4757-0680-2_8
Structural and Functional Aspects of Signal Transduction by Receptor Tyrosine Kinases
Yarden, Y. (1989) · Springer eBooks · doi:10.1007/978-3-642-74415-0_2
Self-citation
Metadata
- Authors
- Yarden, Y., & Schlessinger, J.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1987-03-01
- Volume
- 26
- Issue
- 5
- Pages
- 1443-1451
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2095381863
- Cited by
- 627
- References
- 31
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 8 · 2023: 16 · 2022: 21 · 2021: 5 · 2020: 13 · 2019: 12 · 2018: 14 · 2017: 13 · 2016: 14 · 2015: 19 · 2014: 16 · 2013: 12 · 2012: 11
- FWCI
- 21.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 25820)
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- epidermal growth factor receptor, receptor dimerization, receptor oligomerization, epidermal growth factor, A431 cells, receptor phosphorylation, ligand binding affinity, kinase activation, transmembrane signaling
- MeSH terms
- Allosteric Regulation, Cell Line, Cross-Linking Reagents, Epidermal Growth Factor, Humans, Phosphorylation, Protein Binding, Protein-Tyrosine Kinases, Structure-Activity Relationship, Temperature, Macromolecular Substances, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review